Viguié Schmidt & Associés A.A.R.P.I. advised Nextstage AM in the frame of their €35.5m investment in EurobioNext, a joint venture with two reference shareholders of Eurobio Scientific and aiming at holding a 28.3% stake in Eurobio Scientific.
Members of the team involved in the transaction: